zevalin

Generic: ibritumomab tiuxetan

Labeler: acrotech biopharma inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name zevalin
Generic Name ibritumomab tiuxetan
Labeler acrotech biopharma inc
Dosage Form KIT
Manufacturer
Acrotech Biopharma Inc

Identifiers & Regulatory

Product NDC 72893-007
Product ID 72893-007_c1ec6e37-45bb-4cda-a821-464552c48982
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125019
Listing Expiration 2026-12-31
Marketing Start 2002-02-19

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72893007
Hyphenated Format 72893-007

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zevalin (source: ndc)
Generic Name ibritumomab tiuxetan (source: ndc)
Application Number BLA125019 (source: ndc)

Resolved Composition

Strengths
  • 3.2 mg
  • 2 ml
  • 3.2 mg/2 ml
  • 0.9 %
  • 13.6 mg
  • 750 mg
  • 76 mg
  • 28 mg
  • 4 mg
  • 2 mg
  • 10 ml
source: label
Packaging
  • 1 KIT in 1 CARTON (72893-007-04) * 10 mL in 1 VIAL * 2 mL in 1 VIAL * 2 mL in 1 VIAL
source: ndc

Packages (1)

72893-007-04 1 KIT in 1 CARTON (72893-007-04) * 10 mL in 1 VIAL * 2 mL in 1 VIAL * 2 mL in 1 VIAL

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Zevalin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "c1ec6e37-45bb-4cda-a821-464552c48982", "openfda": {"spl_set_id": ["25d367dc-da65-44c9-a844-1bf15339c285"], "manufacturer_name": ["Acrotech Biopharma Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (72893-007-04)  *  10 mL in 1 VIAL *  2 mL in 1 VIAL *  2 mL in 1 VIAL", "package_ndc": "72893-007-04", "marketing_start_date": "20020219"}], "brand_name": "Zevalin", "product_id": "72893-007_c1ec6e37-45bb-4cda-a821-464552c48982", "dosage_form": "KIT", "product_ndc": "72893-007", "generic_name": "ibritumomab tiuxetan", "labeler_name": "Acrotech Biopharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zevalin", "application_number": "BLA125019", "marketing_category": "BLA", "marketing_start_date": "20020219", "listing_expiration_date": "20261231"}